TG Therapeutics Announces Long-term Follow-up Data from the Phase 2 Trial of Ublituximab in Patients with Multiple Sclerosis Biotech Investing
Lexaria Bioscience Announces CBD-Beverage Formulation License Agreement with Nevada-Based Company Cannabis Investing News
Life Science Big News Roundup: NanoSphere and Stat Shield Technology Form Strategic Partnership; MediPharm Upgrades to the OTCQX Best Market Life Science Investing
NanoSphere Health Sciences and Stat Shield Technology Form Strategic Partnership to Launch Evolve Products for Veterans Biotech Investing
MediPharm Labs Announces Upgrade to the OTCQX Best Market in the U.S. Under Symbol “MEDIF” Cannabis Investing News
